Seres Therapeutics Inc (NAS:MCRB)
$ 0.7589 -0.017 (-2.19%) Market Cap: 114.94 Mil Enterprise Value: 221.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Q1 2019 Seres Therapeutics Inc Earnings Call Transcript

May 02, 2019 / 12:30PM GMT
Release Date Price: $5.35 (-12.44%)
Operator

Good day, ladies and gentlemen. Thank you for standing by, and welcome to Q1 2019 Seres Therapeutics Earnings Conference Call. (Operator Instructions) As a reminder, this conference may be recorded.

At this time, I would like to turn the conference call over to Dr. Carlo Tanzi, Vice President of Investor Relations and Corporate Communications. You may begin.

Carlo Tanzi
Seres Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, and good morning. A press release for the company's first quarter 2019 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors & Media section of the company's website.

I would like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, including changes related to the design of our ECOSPOR III study, regulatory matters, study designs, our development plans, our potential competitive advantages, the promise and potential impact of our microbiome

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot